img

Global Botulinum Toxin Type A Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture

Publisher : MRA | Format : PDF

Global Botulinum Toxin Type A Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
The global Botulinum Toxin Type A market size was US$ 6563.4 million in 2022 and is forecast to a readjusted size of US$ 8335.1 million by 2033 with a CAGR of 3.4% during the forecast period 2023-2033.
Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.
United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.
In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.
In terms of production side, this report researches the Botulinum Toxin Type A capacity, production, growth rate, market share by manufacturers, region level and country level, from 2018 to 2023, and forecast to 2033.
In terms of sales (consumption) side, this report focuses on the sales of Botulinum Toxin Type A by region (Countries), company, type and application. from 2018 to 2023 and forecast to 2033.
The global Botulinum Toxin Type A market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by type segment of the global Botulinum Toxin Type A market. These figures have been provided in terms of both revenue and volume for the period 2018-2033. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.



By Company


ALLERGAN
Galderma
Merz Pharma
DAEWOONG
Ipsen
Pfizer
By Type
50 Units
100 Units
200 Units
By Application
Cosmetic Applications
Therapeutic Applications
Others

Production by Region


North America
Europe
China
Japan
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Botulinum Toxin Type A in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Botulinum Toxin Type A production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4Detailed analysis of Botulinum Toxin Type A manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 9China by company, by type and by application, sales, and revenue for each segment.
Chapter 10APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 11Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 12Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botulinum Toxin Type A sales, revenue, price, gross margin, and recent development, etc.
Chapter 13Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 14Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Botulinum Toxin Type A Definition
1.2 Market by Type
1.2.1 Global Botulinum Toxin Type A Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 50 Units
1.2.3 100 Units
1.2.4 200 Units
1.3 Market by Application
1.3.1 Global Botulinum Toxin Type A Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Cosmetic Applications
1.3.3 Therapeutic Applications
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Botulinum Toxin Type A Sales
2.1 Global Botulinum Toxin Type A Revenue Estimates and Forecasts 2018-2033
2.2 Global Botulinum Toxin Type A Revenue by Region: 2018 VS 2022 VS 2033
2.3 Global Botulinum Toxin Type A Revenue by Region
2.3.1 Global Botulinum Toxin Type A Revenue by Region (2018-2023)
2.3.2 Global Botulinum Toxin Type A Revenue by Region (2024-2033)
2.4 Global Botulinum Toxin Type A Sales Quantity Estimates and Forecasts 2018-2033
2.5 Global Botulinum Toxin Type A Sales Quantity by Region: 2018 VS 2022 VS 2033
2.6 Global Botulinum Toxin Type A Sales Quantity by Region
2.6.1 Global Botulinum Toxin Type A Sales Quantity by Region (2018-2023)
2.6.2 Global Botulinum Toxin Type A Sales Quantity by Region (2024-2033)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Global Production (Based on Production Site)
3.1 Global Botulinum Toxin Type A Production Value by Region: 2018 VS 2022 VS 2033
3.2 Global Botulinum Toxin Type A Production Value by Region
3.2.1 Global Botulinum Toxin Type A Historic Production Value by Region (2018-2023)
3.2.2 Global Botulinum Toxin Type A Forecasted Production Value by Region (2024-2033)
3.3 Global Botulinum Toxin Type A Production Capacity (2018-2033)
3.4 Global Botulinum Toxin Type A Production by Region: 2018 VS 2022 VS 2033
3.5 Global Botulinum Toxin Type A Production by Region
3.5.1 Global Botulinum Toxin Type A Historic Production by Region (2018-2023)
3.5.2 Global Botulinum Toxin Type A Forecasted Production by Region (2024-2033)
3.5.3 North America
3.5.4 Europe
3.5.5 Japan
3.5.6 China
3.5.7 South Korea
3.5.8 India
4 Competition by Manufacturers
4.1 Global Botulinum Toxin Type A Sales Quantity by Manufacturers
4.1.1 Global Botulinum Toxin Type A Sales Quantity by Manufacturers (2018-2023)
4.1.2 Global Botulinum Toxin Type A Sales Quantity Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Companies by Botulinum Toxin Type A Sales in 2022
4.2 Global Botulinum Toxin Type A Revenue by Manufacturers
4.2.1 Global Botulinum Toxin Type A Revenue by Manufacturers (2018-2023)
4.2.2 Global Botulinum Toxin Type A Revenue Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Botulinum Toxin Type A Revenue in 2022
4.3 Global Botulinum Toxin Type A Sales Price by Manufacturers
4.4 Global Key Players of Botulinum Toxin Type A, Industry Ranking, 2021 VS 2022
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Botulinum Toxin Type A Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Botulinum Toxin Type A, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Botulinum Toxin Type A, Product Offered and Application
4.8 Global Key Manufacturers of Botulinum Toxin Type A, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Estimates and Forecasts by Type
5.1 Global Botulinum Toxin Type A Sales Quantity by Type
5.1.1 Global Botulinum Toxin Type A Historical Sales Quantity by Type (2018-2023)
5.1.2 Global Botulinum Toxin Type A Forecasted Sales Quantity by Type (2024-2033)
5.1.3 Global Botulinum Toxin Type A Sales Quantity Market Share by Type (2018-2033)
5.2 Global Botulinum Toxin Type A Revenue by Type
5.2.1 Global Botulinum Toxin Type A Historical Revenue by Type (2018-2023)
5.2.2 Global Botulinum Toxin Type A Forecasted Revenue by Type (2024-2033)
5.2.3 Global Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
5.3 Global Botulinum Toxin Type A Price by Type
5.3.1 Global Botulinum Toxin Type A Price by Type (2018-2023)
5.3.2 Global Botulinum Toxin Type A Price Forecast by Type (2024-2033)
6 Market Size by Application
6.1 Global Botulinum Toxin Type A Sales Quantity by Application
6.1.1 Global Botulinum Toxin Type A Historical Sales Quantity by Application (2018-2023)
6.1.2 Global Botulinum Toxin Type A Forecasted Sales Quantity by Application (2024-2033)
6.1.3 Global Botulinum Toxin Type A Sales Quantity Market Share by Application (2018-2033)
6.2 Global Botulinum Toxin Type A Revenue by Application
6.2.1 Global Botulinum Toxin Type A Historical Revenue by Application (2018-2023)
6.2.2 Global Botulinum Toxin Type A Forecasted Revenue by Application (2024-2033)
6.2.3 Global Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
6.3 Global Botulinum Toxin Type A Price by Application
6.3.1 Global Botulinum Toxin Type A Price by Application (2018-2023)
6.3.2 Global Botulinum Toxin Type A Price Forecast by Application (2024-2033)
7 North America
7.1 North America Botulinum Toxin Type A Sales by Company
7.1.1 North America Botulinum Toxin Type A Revenue by Company (2018-2023)
7.1.2 North America Botulinum Toxin Type A Sales Quantity by Company (2018-2023)
7.2 North America Botulinum Toxin Type A Market Size by Type
7.2.1 North America Botulinum Toxin Type A Sales Quantity by Type (2018-2033)
7.2.2 North America Botulinum Toxin Type A Revenue by Type (2018-2033)
7.3 North America Botulinum Toxin Type A Market Size by Application
7.3.1 North America Botulinum Toxin Type A Sales Quantity by Application (2018-2033)
7.3.2 North America Botulinum Toxin Type A Revenue by Application (2018-2033)
7.4 North America Botulinum Toxin Type A Market Size by Country
7.4.1 North America Botulinum Toxin Type A Revenue by Country: 2018 VS 2022 VS 2033
7.4.2 North America Botulinum Toxin Type A Revenue by Country (2018-2033)
7.4.3 North America Botulinum Toxin Type A Sales Quantity by Country (2018-2033)
7.4.4 U.S.
7.4.5 Canada
8 Europe
8.1 Europe Botulinum Toxin Type A Sales by Company
8.1.1 Europe Botulinum Toxin Type A Sales Quantity by Company (2018-2023)
8.1.2 Europe Botulinum Toxin Type A Revenue by Company (2018-2023)
8.2 Europe Botulinum Toxin Type A Market Size by Type
8.2.1 Europe Botulinum Toxin Type A Sales Quantity by Type (2018-2033)
8.2.2 Europe Botulinum Toxin Type A Revenue by Type (2018-2033)
8.3 Europe Botulinum Toxin Type A Market Size by Application
8.3.1 Europe Botulinum Toxin Type A Sales Quantity by Application (2018-2033)
8.3.2 Europe Botulinum Toxin Type A Revenue by Application (2018-2033)
8.4 Europe Botulinum Toxin Type A Market Size by Country
8.4.1 Europe Botulinum Toxin Type A Revenue by Country: 2018 VS 2022 VS 2033
8.4.2 Europe Botulinum Toxin Type A Revenue by Country (2018-2033)
8.4.3 Europe Botulinum Toxin Type A Sales Quantity by Country (2018-2033)
8.4.4 Germany
8.4.5 France
8.4.6 U.K.
8.4.7 Italy
8.4.8 Russia
9 China
9.1 China Botulinum Toxin Type A Sales by Company
9.1.1 China Botulinum Toxin Type A Sales Quantity by Company (2018-2023)
9.1.2 China Botulinum Toxin Type A Revenue by Company (2018-2023)
9.2 China Botulinum Toxin Type A Market Size by Type
9.2.1 China Botulinum Toxin Type A Sales Quantity by Type (2018-2033)
9.2.2 China Botulinum Toxin Type A Revenue by Type (2018-2033)
9.3 China Botulinum Toxin Type A Market Size by Application
9.3.1 China Botulinum Toxin Type A Sales Quantity by Application (2018-2033)
9.3.2 China Botulinum Toxin Type A Revenue by Application (2018-2033)
10 APAC (excluding China)
10.1 APAC Botulinum Toxin Type A Sales by Company
10.1.1 APAC Botulinum Toxin Type A Sales Quantity by Company (2018-2023)
10.1.2 APAC Botulinum Toxin Type A Revenue by Company (2018-2023)
10.2 APAC Botulinum Toxin Type A Market Size by Type
10.2.1 APAC Botulinum Toxin Type A Sales Quantity by Type (2018-2033)
10.2.2 APAC Botulinum Toxin Type A Revenue by Type (2018-2033)
10.3 APAC Botulinum Toxin Type A Market Size by Application
10.3.1 APAC Botulinum Toxin Type A Sales Quantity by Application (2018-2033)
10.3.2 APAC Botulinum Toxin Type A Revenue by Application (2018-2033)
10.4 APAC Botulinum Toxin Type A Market Size by Region
10.4.1 APAC Botulinum Toxin Type A Revenue by Region: 2018 VS 2022 VS 2033
10.4.2 APAC Botulinum Toxin Type A Revenue by Region (2018-2033)
10.4.3 APAC Botulinum Toxin Type A Sales Quantity by Region (2018-2033)
10.4.4 Japan
10.4.5 South Korea
10.4.6 China Taiwan
10.4.7 Southeast Asia
10.4.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Company
11.1.1 Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity by Company (2018-2023)
11.1.2 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Company (2018-2023)
11.2 Middle East, Africa and Latin America Botulinum Toxin Type A Market Size by Type
11.2.1 Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity by Type (2018-2033)
11.2.2 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Type (2018-2033)
11.3 Middle East, Africa and Latin America Botulinum Toxin Type A Market Size by Application
11.3.1 Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity by Application (2018-2033)
11.3.2 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Application (2018-2033)
11.4 Middle East, Africa and Latin America Botulinum Toxin Type A Market Size by Country
11.4.1 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Country: 2018 VS 2022 VS 2033
11.4.2 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Country (2018-2033)
11.4.3 Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity by Country (2018-2033)
11.4.4 Brazil
11.4.5 Mexico
11.4.6 Turkey
11.4.7 Israel
11.4.8 GCC Countries
12 Company Profiles
12.1 ALLERGAN
12.1.1 ALLERGAN Company Information
12.1.2 ALLERGAN Overview
12.1.3 ALLERGAN Botulinum Toxin Type A Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
12.1.4 ALLERGAN Botulinum Toxin Type A Products and Services
12.1.5 ALLERGAN Botulinum Toxin Type A SWOT Analysis
12.1.6 ALLERGAN Recent Developments
12.2 Galderma
12.2.1 Galderma Company Information
12.2.2 Galderma Overview
12.2.3 Galderma Botulinum Toxin Type A Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
12.2.4 Galderma Botulinum Toxin Type A Products and Services
12.2.5 Galderma Botulinum Toxin Type A SWOT Analysis
12.2.6 Galderma Recent Developments
12.3 Merz Pharma
12.3.1 Merz Pharma Company Information
12.3.2 Merz Pharma Overview
12.3.3 Merz Pharma Botulinum Toxin Type A Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
12.3.4 Merz Pharma Botulinum Toxin Type A Products and Services
12.3.5 Merz Pharma Botulinum Toxin Type A SWOT Analysis
12.3.6 Merz Pharma Recent Developments
12.4 DAEWOONG
12.4.1 DAEWOONG Company Information
12.4.2 DAEWOONG Overview
12.4.3 DAEWOONG Botulinum Toxin Type A Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
12.4.4 DAEWOONG Botulinum Toxin Type A Products and Services
12.4.5 DAEWOONG Botulinum Toxin Type A SWOT Analysis
12.4.6 DAEWOONG Recent Developments
12.5 Ipsen
12.5.1 Ipsen Company Information
12.5.2 Ipsen Overview
12.5.3 Ipsen Botulinum Toxin Type A Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
12.5.4 Ipsen Botulinum Toxin Type A Products and Services
12.5.5 Ipsen Botulinum Toxin Type A SWOT Analysis
12.5.6 Ipsen Recent Developments
12.6 Pfizer
12.6.1 Pfizer Company Information
12.6.2 Pfizer Overview
12.6.3 Pfizer Botulinum Toxin Type A Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
12.6.4 Pfizer Botulinum Toxin Type A Products and Services
12.6.5 Pfizer Botulinum Toxin Type A SWOT Analysis
12.6.6 Pfizer Recent Developments
13 Value Chain and Sales Channels Analysis
13.1 Botulinum Toxin Type A Value Chain Analysis
13.2 Botulinum Toxin Type A Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Botulinum Toxin Type A Production Mode & Process
13.4 Botulinum Toxin Type A Sales and Marketing
13.4.1 Botulinum Toxin Type A Sales Channels
13.4.2 Botulinum Toxin Type A Distributors
13.5 Botulinum Toxin Type A Customers
14 Market Dynamics
14.1 Botulinum Toxin Type A Industry Trends
14.2 Botulinum Toxin Type A Market Drivers
14.3 Botulinum Toxin Type A Market Challenges
14.4 Botulinum Toxin Type A Market Restraints
15 Key Findings
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Botulinum Toxin Type A Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2033 (US$ Million)
Table 2. Major Manufacturers of 50 Units
Table 3. Major Manufacturers of 100 Units
Table 4. Major Manufacturers of 200 Units
Table 5. Global Botulinum Toxin Type A Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2033 (US$ Million)
Table 6. Global Botulinum Toxin Type A Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. Global Botulinum Toxin Type A Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Botulinum Toxin Type A Revenue Market Share by Region (2018-2023)
Table 9. Global Botulinum Toxin Type A Revenue by Region (2024-2033) & (US$ Million)
Table 10. Global Botulinum Toxin Type A Revenue Market Share by Region (2024-2033)
Table 11. Global Botulinum Toxin Type A Sales Quantity by Region: 2018 VS 2022 VS 2033 (K MT)
Table 12. Global Botulinum Toxin Type A Sales by Region (2018-2023) & (K MT)
Table 13. Global Botulinum Toxin Type A Sales Market Share by Region (2018-2023)
Table 14. Global Botulinum Toxin Type A Sales by Region (2024-2033) & (K MT)
Table 15. Global Botulinum Toxin Type A Sales Market Share by Region (2024-2033)
Table 16. Global Botulinum Toxin Type A Production Value Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 17. Global Botulinum Toxin Type A Production Value by Region (2018-2023) & (US$ Million)
Table 18. Global Botulinum Toxin Type A Production Value Market Share by Region (2018-2023)
Table 19. Global Botulinum Toxin Type A Production Value by Region (2024-2033) & (US$ Million)
Table 20. Global Botulinum Toxin Type A Production Value Market Share by Region (2024-2033)
Table 21. Global Botulinum Toxin Type A Production Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (K MT)
Table 22. Global Botulinum Toxin Type A Production by Region (2018-2023) & (K MT)
Table 23. Global Botulinum Toxin Type A Production Market Share by Region (2018-2023)
Table 24. Global Botulinum Toxin Type A Production by Region (2024-2033) & (K MT)
Table 25. Global Botulinum Toxin Type A Production Market Share by Region (2024-2033)
Table 26. Global Botulinum Toxin Type A Sales Quantity by Manufacturers (2018-2023) & (K MT)
Table 27. Global Botulinum Toxin Type A Sales Quantity Share by Manufacturers (2018-2023)
Table 28. Global Botulinum Toxin Type A Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 29. Global Botulinum Toxin Type A Revenue Share by Manufacturers (2018-2023)
Table 30. Global Botulinum Toxin Type A Price by Manufacturers 2018-2023 (USD/MT)
Table 31. Global Key Players of Botulinum Toxin Type A, Industry Ranking, 2021 VS 2022
Table 32. Global Botulinum Toxin Type A Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Botulinum Toxin Type A by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulinum Toxin Type A as of 2022)
Table 34. Global Key Manufacturers of Botulinum Toxin Type A, Manufacturing Base Distribution and Headquarters
Table 35. Global Key Manufacturers of Botulinum Toxin Type A, Product Offered and Application
Table 36. Global Key Manufacturers of Botulinum Toxin Type A, Date of Enter into This Industry
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Botulinum Toxin Type A Sales Quantity by Type (2018-2023) & (K MT)
Table 39. Global Botulinum Toxin Type A Sales Quantity by Type (2024-2033) & (K MT)
Table 40. Global Botulinum Toxin Type A Sales Quantity Share by Type (2018-2023)
Table 41. Global Botulinum Toxin Type A Sales Quantity Share by Type (2024-2033)
Table 42. Global Botulinum Toxin Type A Revenue by Type (2018-2023) & (US$ Million)
Table 43. Global Botulinum Toxin Type A Revenue by Type (2024-2033) & (US$ Million)
Table 44. Global Botulinum Toxin Type A Revenue Share by Type (2018-2023)
Table 45. Global Botulinum Toxin Type A Revenue Share by Type (2024-2033)
Table 46. Botulinum Toxin Type A Price by Type (2018-2023) & (USD/MT)
Table 47. Global Botulinum Toxin Type A Price Forecast by Type (2024-2033) & (USD/MT)
Table 48. Global Botulinum Toxin Type A Sales Quantity by Application (2018-2023) & (K MT)
Table 49. Global Botulinum Toxin Type A Sales Quantity by Application (2024-2033) & (K MT)
Table 50. Global Botulinum Toxin Type A Sales Quantity Share by Application (2018-2023)
Table 51. Global Botulinum Toxin Type A Sales Quantity Share by Application (2024-2033)
Table 52. Global Botulinum Toxin Type A Revenue by Application (2018-2023) & (US$ Million)
Table 53. Global Botulinum Toxin Type A Revenue by Application (2024-2033) & (US$ Million)
Table 54. Global Botulinum Toxin Type A Revenue Share by Application (2018-2023)
Table 55. Global Botulinum Toxin Type A Revenue Share by Application (2024-2033)
Table 56. Botulinum Toxin Type A Price by Application (2018-2023) & (USD/MT)
Table 57. Global Botulinum Toxin Type A Price Forecast by Application (2024-2033) & (USD/MT)
Table 58. North America Botulinum Toxin Type A Revenue by Company (2018-2023) & (US$ Million)
Table 59. North America Botulinum Toxin Type A Sales Quantity by Company (2018-2023) & (K MT)
Table 60. North America Botulinum Toxin Type A Sales Quantity by Type (2018-2023) & (K MT)
Table 61. North America Botulinum Toxin Type A Sales Quantity by Type (2024-2033) & (K MT)
Table 62. North America Botulinum Toxin Type A Revenue by Type (2018-2023) & (US$ Million)
Table 63. North America Botulinum Toxin Type A Revenue by Type (2024-2033) & (US$ Million)
Table 64. North America Botulinum Toxin Type A Sales Quantity by Application (2018-2023) & (K MT)
Table 65. North America Botulinum Toxin Type A Sales Quantity by Application (2024-2033) & (K MT)
Table 66. North America Botulinum Toxin Type A Revenue by Application (2018-2023) & (US$ Million)
Table 67. North America Botulinum Toxin Type A Revenue by Application (2024-2033) & (US$ Million)
Table 68. North America Botulinum Toxin Type A Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 69. North America Botulinum Toxin Type A Revenue by Country (2018-2023) & (US$ Million)
Table 70. North America Botulinum Toxin Type A Revenue by Country (2024-2033) & (US$ Million)
Table 71. North America Botulinum Toxin Type A Sales Quantity by Country (2018-2023) & (K MT)
Table 72. North America Botulinum Toxin Type A Sales Quantity by Country (2024-2033) & (K MT)
Table 73. Europe Botulinum Toxin Type A Sales Quantity by Company (2018-2023) & (K MT)
Table 74. Europe Botulinum Toxin Type A Revenue by Company (2018-2023) & (US$ Million)
Table 75. Europe Botulinum Toxin Type A Sales Quantity by Type (2018-2023) & (K MT)
Table 76. Europe Botulinum Toxin Type A Sales Quantity by Type (2024-2033) & (K MT)
Table 77. Europe Botulinum Toxin Type A Revenue by Type (2018-2023) & (US$ Million)
Table 78. Europe Botulinum Toxin Type A Revenue by Type (2024-2033) & (US$ Million)
Table 79. Europe Botulinum Toxin Type A Sales Quantity by Application (2018-2023) & (K MT)
Table 80. Europe Botulinum Toxin Type A Sales Quantity by Application (2024-2033) & (K MT)
Table 81. Europe Botulinum Toxin Type A Revenue by Application (2018-2023) & (US$ Million)
Table 82. Europe Botulinum Toxin Type A Revenue by Application (2024-2033) & (US$ Million)
Table 83. Europe Botulinum Toxin Type A Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 84. Europe Botulinum Toxin Type A Revenue by Country (2018-2023) & (US$ Million)
Table 85. Europe Botulinum Toxin Type A Revenue by Country (2024-2033) & (US$ Million)
Table 86. Europe Botulinum Toxin Type A Sales Quantity by Country (2018-2023) & (K MT)
Table 87. Europe Botulinum Toxin Type A Sales Quantity by Country (2024-2033) & (K MT)
Table 88. China Botulinum Toxin Type A Sales Quantity by Company (2018-2023) & (K MT)
Table 89. China Botulinum Toxin Type A Revenue by Company (2018-2023) & (US$ Million)
Table 90. China Botulinum Toxin Type A Sales Quantity by Type (2018-2023) & (K MT)
Table 91. China Botulinum Toxin Type A Sales Quantity by Type (2024-2033) & (K MT)
Table 92. China Botulinum Toxin Type A Revenue by Type (2018-2023) & (US$ Million)
Table 93. China Botulinum Toxin Type A Revenue by Type (2024-2033) & (US$ Million)
Table 94. China Botulinum Toxin Type A Sales Quantity by Application (2018-2023) & (K MT)
Table 95. China Botulinum Toxin Type A Sales Quantity by Application (2024-2033) & (K MT)
Table 96. China Botulinum Toxin Type A Revenue by Application (2018-2023) & (US$ Million)
Table 97. China Botulinum Toxin Type A Revenue by Application (2024-2033) & (US$ Million)
Table 98. APAC Botulinum Toxin Type A Sales Quantity by Company (2018-2023) & (K MT)
Table 99. APAC Botulinum Toxin Type A Revenue by Company (2018-2023) & (US$ Million)
Table 100. APAC Botulinum Toxin Type A Sales Quantity by Type (2018-2023) & (K MT)
Table 101. APAC Botulinum Toxin Type A Sales Quantity by Type (2024-2033) & (K MT)
Table 102. APAC Botulinum Toxin Type A Revenue by Type (2018-2023) & (US$ Million)
Table 103. APAC Botulinum Toxin Type A Revenue by Type (2024-2033) & (US$ Million)
Table 104. APAC Botulinum Toxin Type A Sales Quantity by Application (2018-2023) & (K MT)
Table 105. APAC Botulinum Toxin Type A Sales Quantity by Application (2024-2033) & (K MT)
Table 106. APAC Botulinum Toxin Type A Revenue by Application (2018-2023) & (US$ Million)
Table 107. APAC Botulinum Toxin Type A Revenue by Application (2024-2033) & (US$ Million)
Table 108. APAC Botulinum Toxin Type A Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 109. APAC Botulinum Toxin Type A Revenue by Region (2018-2023) & (US$ Million)
Table 110. APAC Botulinum Toxin Type A Revenue by Region (2024-2033) & (US$ Million)
Table 111. APAC Botulinum Toxin Type A Sales Quantity by Region (2018-2023) & (K MT)
Table 112. APAC Botulinum Toxin Type A Sales Quantity by Region (2024-2033) & (K MT)
Table 113. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity by Company (2018-2023) & (K MT)
Table 114. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Company (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity by Type (2018-2023) & (K MT)
Table 116. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity by Type (2024-2033) & (K MT)
Table 117. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Type (2018-2023) & (US$ Million)
Table 118. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Type (2024-2033) & (US$ Million)
Table 119. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity by Application (2018-2023) & (K MT)
Table 120. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity by Application (2024-2033) & (K MT)
Table 121. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Application (2018-2023) & (US$ Million)
Table 122. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Application (2024-2033) & (US$ Million)
Table 123. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 124. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Country (2018-2023) & (US$ Million)
Table 125. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Country (2024-2033) & (US$ Million)
Table 126. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity by Country (2018-2023) & (K MT)
Table 127. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity by Country (2024-2033) & (K MT)
Table 128. ALLERGAN Company Information
Table 129. ALLERGAN Description and Overview
Table 130. ALLERGAN Botulinum Toxin Type A Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2018-2023)
Table 131. ALLERGAN Botulinum Toxin Type A Products and Services
Table 132. ALLERGAN Botulinum Toxin Type A SWOT Analysis
Table 133. ALLERGAN Recent Development
Table 134. Galderma Company Information
Table 135. Galderma Description and Overview
Table 136. Galderma Botulinum Toxin Type A Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2018-2023)
Table 137. Galderma Botulinum Toxin Type A Products and Services
Table 138. Galderma Botulinum Toxin Type A SWOT Analysis
Table 139. Galderma Recent Development
Table 140. Merz Pharma Company Information
Table 141. Merz Pharma Description and Overview
Table 142. Merz Pharma Botulinum Toxin Type A Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2018-2023)
Table 143. Merz Pharma Botulinum Toxin Type A Products and Services
Table 144. Merz Pharma Botulinum Toxin Type A SWOT Analysis
Table 145. Merz Pharma Recent Development
Table 146. DAEWOONG Company Information
Table 147. DAEWOONG Description and Overview
Table 148. DAEWOONG Botulinum Toxin Type A Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2018-2023)
Table 149. DAEWOONG Botulinum Toxin Type A Products and Services
Table 150. DAEWOONG Botulinum Toxin Type A SWOT Analysis
Table 151. DAEWOONG Recent Development
Table 152. Ipsen Company Information
Table 153. Ipsen Description and Overview
Table 154. Ipsen Botulinum Toxin Type A Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2018-2023)
Table 155. Ipsen Botulinum Toxin Type A Products and Services
Table 156. Ipsen Botulinum Toxin Type A SWOT Analysis
Table 157. Ipsen Recent Development
Table 158. Pfizer Company Information
Table 159. Pfizer Description and Overview
Table 160. Pfizer Botulinum Toxin Type A Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2018-2023)
Table 161. Pfizer Botulinum Toxin Type A Products and Services
Table 162. Pfizer Botulinum Toxin Type A SWOT Analysis
Table 163. Pfizer Recent Development
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Botulinum Toxin Type A Distributors List
Table 167. Botulinum Toxin Type A Customers List
Table 168. Botulinum Toxin Type A Market Trends
Table 169. Botulinum Toxin Type A Market Drivers
Table 170. Botulinum Toxin Type A Market Challenges
Table 171. Botulinum Toxin Type A Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Botulinum Toxin Type A Product Picture
Figure 2. Global Botulinum Toxin Type A Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Botulinum Toxin Type A Market Share by Type in 2022 & 2033
Figure 4. 50 Units Product Picture
Figure 5. 100 Units Product Picture
Figure 6. 200 Units Product Picture
Figure 7. Global Botulinum Toxin Type A Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Botulinum Toxin Type A Market Share by Application in 2022 & 2033
Figure 9. Cosmetic Applications
Figure 10. Therapeutic Applications
Figure 11. Others
Figure 12. Botulinum Toxin Type A Report Years Considered
Figure 13. Global Botulinum Toxin Type A Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Botulinum Toxin Type A Revenue 2018-2033 (US$ Million)
Figure 15. Global Botulinum Toxin Type A Revenue Market Share by Region in Percentage: 2022 Versus 2033
Figure 16. Global Botulinum Toxin Type A Sales Quantity 2018-2033 (K MT)
Figure 17. Global Botulinum Toxin Type A Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Botulinum Toxin Type A Sales Quantity Market Share by Region (2024-2033)
Figure 19. North America Botulinum Toxin Type A Sales Quantity YoY (2018-2033) & (K MT)
Figure 20. North America Botulinum Toxin Type A Revenue YoY (2018-2033) & (US$ Million)
Figure 21. Europe Botulinum Toxin Type A Sales Quantity YoY (2018-2033) & (K MT)
Figure 22. Europe Botulinum Toxin Type A Revenue YoY (2018-2033) & (US$ Million)
Figure 23. China Botulinum Toxin Type A Sales Quantity YoY (2018-2033) & (K MT)
Figure 24. China Botulinum Toxin Type A Revenue YoY (2018-2033) & (US$ Million)
Figure 25. APAC Botulinum Toxin Type A Sales Quantity YoY (2018-2033) & (K MT)
Figure 26. APAC Botulinum Toxin Type A Revenue YoY (2018-2033) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity YoY (2018-2033) & (K MT)
Figure 28. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue YoY (2018-2033) & (US$ Million)
Figure 29. Global Botulinum Toxin Type A Production Value by Region: 2018 VS 2022 VS 2033 (US$ Million)
Figure 30. Global Botulinum Toxin Type A Production Value Market Share by Region in Percentage: 2022 Versus 2033
Figure 31. Global Botulinum Toxin Type A Capacity, Production and Utilization (2018-2033) & (K MT)
Figure 32. Global Botulinum Toxin Type A Production by Region: 2018 VS 2022 VS 2033 (K MT)
Figure 33. Global Botulinum Toxin Type A Production Market Share by Region in Percentage: 2022 Versus 2033
Figure 34. Botulinum Toxin Type A Production Growth Rate in North America (2018-2033) & (K MT)
Figure 35. Botulinum Toxin Type A Production Growth Rate in Europe (2018-2033) & (K MT)
Figure 36. Botulinum Toxin Type A Production Growth Rate in Japan (2018-2033) & (K MT)
Figure 37. Botulinum Toxin Type A Production Growth Rate in China (2018-2033) & (K MT)
Figure 38. Botulinum Toxin Type A Production Growth Rate in South Korea (2018-2033) & (K MT)
Figure 39. Botulinum Toxin Type A Production Growth Rate in India (2018-2033) & (K MT)
Figure 40. The Top 10 and Top 5 Players Market Share by Botulinum Toxin Type A Sales Quantity in 2022
Figure 41. The Top 10 and Top 5 Players Market Share by Botulinum Toxin Type A Revenue in 2022
Figure 42. Botulinum Toxin Type A Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 43. Global Botulinum Toxin Type A Sales Quantity Market Share by Type (2018-2033)
Figure 44. Global Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
Figure 45. Global Botulinum Toxin Type A Sales Quantity Market Share by Application (2018-2033)
Figure 46. Global Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
Figure 47. North America Botulinum Toxin Type A Revenue Market Share by Company in 2022
Figure 48. North America Botulinum Toxin Type A Sales Quantity Market Share by Company in 2022
Figure 49. North America Botulinum Toxin Type A Sales Quantity Market Share by Type (2018-2033)
Figure 50. North America Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
Figure 51. North America Botulinum Toxin Type A Sales Quantity Market Share by Application (2018-2033)
Figure 52. North America Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
Figure 53. North America Botulinum Toxin Type A Revenue Share by Country (2018-2033)
Figure 54. North America Botulinum Toxin Type A Sales Quantity Share by Country (2018-2033)
Figure 55. U.S. Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 56. Canada Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 57. Europe Botulinum Toxin Type A Sales Quantity Market Share by Company in 2022
Figure 58. Europe Botulinum Toxin Type A Revenue Market Share by Company in 2022
Figure 59. Europe Botulinum Toxin Type A Sales Quantity Market Share by Type (2018-2033)
Figure 60. Europe Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
Figure 61. Europe Botulinum Toxin Type A Sales Quantity Market Share by Application (2018-2033)
Figure 62. Europe Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
Figure 63. Europe Botulinum Toxin Type A Revenue Share by Country (2018-2033)
Figure 64. Europe Botulinum Toxin Type A Sales Quantity Share by Country (2018-2033)
Figure 65. Germany Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 66. France Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 67. U.K. Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 68. Italy Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 69. Russia Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 70. China Botulinum Toxin Type A Sales Quantity Market Share by Company in 2022
Figure 71. China Botulinum Toxin Type A Revenue Market Share by Company in 2022
Figure 72. China Botulinum Toxin Type A Sales Quantity Market Share by Type (2018-2033)
Figure 73. China Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
Figure 74. China Botulinum Toxin Type A Sales Quantity Market Share by Application (2018-2033)
Figure 75. China Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
Figure 76. APAC Botulinum Toxin Type A Sales Quantity Market Share by Company in 2022
Figure 77. APAC Botulinum Toxin Type A Revenue Market Share by Company in 2022
Figure 78. APAC Botulinum Toxin Type A Sales Quantity Market Share by Type (2018-2033)
Figure 79. APAC Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
Figure 80. APAC Botulinum Toxin Type A Sales Quantity Market Share by Application (2018-2033)
Figure 81. APAC Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
Figure 82. APAC Botulinum Toxin Type A Revenue Share by Region (2018-2033)
Figure 83. APAC Botulinum Toxin Type A Sales Quantity Share by Region (2018-2033)
Figure 84. Japan Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 85. South Korea Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 86. China Taiwan Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 87. Southeast Asia Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 88. India Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 89. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity Market Share by Company in 2022
Figure 90. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue Market Share by Company in 2022
Figure 91. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity Market Share by Type (2018-2033)
Figure 92. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
Figure 93. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity Market Share by Application (2018-2033)
Figure 94. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
Figure 95. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Quantity Share by Country (2018-2033)
Figure 96. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue Share by Country (2018-2033)
Figure 97. Brazil Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 98. Mexico Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 99. Turkey Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 100. Israel Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 101. GCC Countries Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 102. Botulinum Toxin Type A Value Chain
Figure 103. Botulinum Toxin Type A Production Process
Figure 104. Channels of Distribution (Direct Vs Distribution)
Figure 105. Distributors Profiles
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed